AGP Executive Report
Last update: 10 hours agoCancer Care in Europe: The EU Commission has approved pembrolizumab (Keytruda) plus enfortumab vedotin (Padcev) as a perioperative treatment for adults with resectable muscle-invasive bladder cancer who can’t have cisplatin, with the option to continue after surgery—also covering Iceland. Health Funding Link: North Macedonia has been added to the EU4Health programme, letting health authorities access funding from 1 January 2026 to boost prevention, cancer and cardiovascular care, mental health, and medicines planning. Wellness Science: A new look at sauna research highlights strong associations with lower cardiovascular death risk in long-running studies, with benefits appearing dose-dependent. Local Health Costs (Europe): Netherlands health spending rose 6.1% in 2025, with long-term care the fastest-growing part. Pregnancy Protections (Sports): A CAS ruling backs a footballer’s pregnancy-related confidentiality and compensation rights after a club ended her contract. Public Health Watch: A report flags rising antimicrobial resistance risks, including pharmaceutical contamination in water. Iceland Angle: Iceland is named in multiple EU health and healthcare access updates, including EU4Health and cancer approvals.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
